U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health announces the availability of funding for implementation of the Mood and Psychosis Symptoms During the Menopause Transition (R21 Clinical Trial Optional) Exploratory/Developmental Research Grant. The purpose of this grant is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression, generalized anxiety disorder, bipolar disorder, and schizophrenia) during the menopause transition in an effort to identity targets for future development of novel treatment interventions. The R21 exploratory/developmental grant supports investigation of . . .